US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Quoin Pharmaceuticals

5.67

+0.19143.49%

Post-market: 5.950.2800+4.94%16:50 EDT

Volume:79.31K

Turnover:460.32K

Market Cap:3.33M

PE:-0.08

High:6.23

Open:5.29

Low:5.27

Close:5.48

Loading ...

Overview Company News Filings

Quoin Pharmaceuticals releases second episode of ‘Living with Netherton’ series

Quoin Pharmaceuticals Releases Second Episode of its “Living with Netherton” Series, as part of its ongoing NETHERTON NOW awareness campaign

Quoin Pharmaceuticals Ltd – ADR trading halted, news pending

Quoin Pharmaceuticals Changes ADS Ratio to Meet Nasdaq Rule

MT Newswires Live

ADRs Advance; Quoin Pharmaceuticals Ltd. Climbs 38%

Quoin Pharmaceuticals - Subject's Skin Almost Completely Healed After 6 Weeks Of Qrx003

Quoin Pharmaceuticals Files U.S. Patent Application for Novel Topical Formulations to Treat Netherton Syndrome and Other Skin Diseases

QNRX: With Clinical Activities Expanding, QNRX Expects Cash Runway Into 2Q26

Zacks Small Cap Research

Quoin Pharmaceuticals Ltd reports results for the quarter ended December 31 - Earnings Summary

Quoin Pharmaceuticals FY 2024 GAAP EPS $(1.91) Beats $(2.10) Estimate, Quoin Had Approximately $14.1M In Cash, Cash Equivalents And Marketable That Is Expected To Fund The Company's Operations Into Q2 Of 2026

Quoin Pharmaceuticals reports Q4 EPS (35c) vs ($2.08) last year

Quoin Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2024 Financial Results

Quoin Pharmaceuticals Ltd expected to post a loss of 46 cents a share - Earnings Preview

Quoin Pharmaceuticals to Announce Fourth Quarter and Full-Year 2024 Financial Results on Thursday, March 13, 2025

QNRX: More Positive Data Supporting Efficacy of QRX003 for NS; Campaign to Raise Awareness of the Disease

Zacks Small Cap Research

Calendar of U.S. Earnings Expected in the Week Ahead

Quoin Pharmaceuticals Files U.S. and International Patent Applications for Novel Topical Rapamycin Formulations to Treat Rare Disease Indications

Quoin Pharmaceuticals Announces Highly Positive ‘Whole Body’ Clinical Data from Ongoing Pediatric Netherton Syndrome Study

Quoin Pharmaceuticals Launches First Episode of “NETHERTON NOW” Video Series to Raise Awareness for Netherton Syndrome

Quoin Pharmaceuticals launches ‘NETHERTON NOW’ campaign

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/QNRX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"QNRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"QNRX\",,,,,undefined,":{"symbol":"QNRX","market":"US","secType":"STK","nameCN":"Quoin Pharmaceuticals","latestPrice":5.67,"timestamp":1745265600000,"preClose":5.4786,"halted":0,"volume":79310,"hourTrading":{"tag":"盘后","latestPrice":5.95,"preClose":5.67,"latestTime":"16:50 EDT","volume":396,"amount":2295.7199892,"timestamp":1745268634100},"delay":0,"floatShares":546540,"shares":588166,"eps":-66.90209,"marketStatus":"Post-Mkt","change":0.1914,"latestTime":"04-21 18:39:21 EDT","open":5.29,"high":6.2346,"low":5.27,"amount":460320.982044,"amplitude":0.176067,"askPrice":6.1,"askSize":100,"bidPrice":5,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-66.90209,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1745280000000},"marketStatusCode":4,"adr":0,"adrRate":35,"exchange":"NASDAQ","adjPreClose":5.4786,"preHourTrading":{"tag":"盘前","latestPrice":5.48,"preClose":5.51,"latestTime":"08:54 EDT","volume":99,"amount":542.0199906,"timestamp":1745240042463},"postHourTrading":{"tag":"盘后","latestPrice":5.95,"preClose":5.67,"latestTime":"16:50 EDT","volume":396,"amount":2295.7199892,"timestamp":1745268634100},"volumeRatio":1.672501},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"QNRX\",,,,,undefined,":{"symbol":"QNRX","floatShares":546540,"roa":"-42.72%","roe":"-120.55%","lyrEps":-66.902093,"volumeRatio":1.672501,"shares":588166,"dividePrice":0,"high":6.2346,"amplitude":0.176067,"preClose":5.4786,"low":5.27,"week52Low":5.01,"pbRate":"0.36","week52High":54.95,"institutionHeld":0,"latestPrice":5.67,"eps":-66.90209,"divideRate":0,"volume":79310,"delay":0,"ttmEps":-66.90209,"open":5.29,"prevYearClose":22.7745,"prevWeekClose":5.4786,"prevMonthClose":7.8365,"prevQuarterClose":7.8365,"fiveDayClose":5.37,"twentyDayClose":10.5,"sixtyDayClose":14.399},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"QNRX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2526503735","title":"Quoin Pharmaceuticals releases second episode of ‘Living with Netherton’ series","url":"https://stock-news.laohu8.com/highlight/detail?id=2526503735","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526503735?lang=en_us&edition=fundamental","pubTime":"2025-04-10 19:35","pubTimestamp":1744284944,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals (QNRX) announced the release of the second episode in its “Living with Netherton” video series, part of the company’s broader...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/quoin-pharmaceuticals-releases-second-episode-of-living-with-netherton-series?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/quoin-pharmaceuticals-releases-second-episode-of-living-with-netherton-series?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","QNRX"],"gpt_icon":0},{"id":"2526557064","title":"Quoin Pharmaceuticals Releases Second Episode of its “Living with Netherton” Series, as part of its ongoing NETHERTON NOW awareness campaign","url":"https://stock-news.laohu8.com/highlight/detail?id=2526557064","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526557064?lang=en_us&edition=fundamental","pubTime":"2025-04-10 19:30","pubTimestamp":1744284600,"startTime":"0","endTime":"0","summary":"Episode Highlights a Truly Remarkable Patient Story Spanning 79 Years Video features 79-year-old Norma Coles, believed to be among the earliest individuals ever evaluated for Netherton Syndrome and is","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/10/3059145/0/en/Quoin-Pharmaceuticals-Releases-Second-Episode-of-its-Living-with-Netherton-Series-as-part-of-its-ongoing-NETHERTON-NOW-awareness-campaign.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1974910355.USD","IE00BMPRXN33.USD","LU2106854487.HKD","LU1989764748.USD","BK4588","BK4528","IE00B894F039.SGD","LU1917777945.USD","ETH","LU0820561909.HKD","LU0689472784.USD","BK4613","LU0265550359.USD","LU2543165471.USD","LU0348723411.USD","LU0708995401.HKD","LU1116320737.USD","BK4608","LU1267930730.SGD","LU1116320901.HKD","BK4534","IE00B19Z9P08.USD","LU0889565833.HKD","LU2023250843.SGD","LU1803068979.SGD","LU2125909916.SGD","LU0109392836.USD","LU1064131342.USD","LU0353189763.USD","LU2286300806.USD","BK4139","BK4543","LU0353189680.USD","LU1989772923.USD","LU2125909593.SGD","LU0719512351.SGD","BK4097","LU0265550946.USD","LU0354030511.USD","LU0081259029.USD","LU1923622291.USD","LU0320765059.SGD","LU1323610961.USD","QNRX","LU2087625088.SGD","BK4585","LU1988902786.USD","NOW","LU0082616367.USD","BK4601"],"gpt_icon":0},{"id":"2526827062","title":"Quoin Pharmaceuticals Ltd – ADR trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2526827062","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526827062?lang=en_us&edition=fundamental","pubTime":"2025-04-09 07:50","pubTimestamp":1744156239,"startTime":"0","endTime":"0","summary":"19:50 EDT Quoin Pharmaceuticals (QNRX) Ltd – ADR trading halted, news pending Published first on TheFly – the ultimate source for real-time, market...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/quoin-pharmaceuticals-ltd-adr-trading-halted-news-pending?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/quoin-pharmaceuticals-ltd-adr-trading-halted-news-pending?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QNRX","BK4139"],"gpt_icon":0},{"id":"2525551733","title":"Quoin Pharmaceuticals Changes ADS Ratio to Meet Nasdaq Rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2525551733","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525551733?lang=en_us&edition=fundamental","pubTime":"2025-04-05 00:59","pubTimestamp":1743785977,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals  said Friday its board approved a ratio change of its American Depositary Shares to raise its share price to meet Nasdaq's $1.00 minimum bid price per share rule.The ratio will change to one ADS representing 20 shares from one ADS representing one share, effective April 8, Quoin said. The change will result in a 1-for-20 reverse split of its ADSs.Price: 0.24, Change: -0.02, Percent Change: -7.30","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2095319765.USD","LU2210150020.SGD",".IXIC","IE00B3QW5Z07.USD","QNRX","NQmain","BK4585","LU2210149790.SGD","IE00B64PRP62.GBP","BK4588","IE00BGHQF748.EUR","IE00BKPKM429.USD","BK4112","NDAQ","74907L409","BK4139"],"gpt_icon":0},{"id":"2524498446","title":"ADRs Advance; Quoin Pharmaceuticals Ltd. Climbs 38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2524498446","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524498446?lang=en_us&edition=fundamental","pubTime":"2025-04-03 04:30","pubTimestamp":1743625800,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.International stocks trading in New York closed higher on Wednesday, as the S&P/BNY Mellon index of American depositary receipts added 0.2% to 188.47.The European index rose 0.3% to 175.34. The Asian index rose 0.2% to 237.03. The Latin American index declined 0.3% to 193.31, while the emerging-markets index rose 0.2% to 381.73.Israel's Quoin Pharmaceuticals Ltd. was the biggest leader during the session, soaring 38% to 29 cents, and United Kingdom-based Biodexa Pharmaceuticals PLC rocketed 28% to $1.54. Adaptimmune Therapeutics PLC, which is based in United Kingdom, rounded out the top three leaders on Wednesday, with shares soaring 22% to 30 cents.BingEx Ltd., based in China, posted the largest decline, cratering 57% to $2.25, followed by shares of Singapore's Trident Digital Tech Holdings Ltd., which cratered 23% to 23 cents. Shares of China-based Adagene Inc. dropped 9.6% to $1.64.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","QNRX","74907L409"],"gpt_icon":0},{"id":"2524641724","title":"Quoin Pharmaceuticals - Subject's Skin Almost Completely Healed After 6 Weeks Of Qrx003","url":"https://stock-news.laohu8.com/highlight/detail?id=2524641724","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524641724?lang=en_us&edition=fundamental","pubTime":"2025-04-02 19:45","pubTimestamp":1743594335,"startTime":"0","endTime":"0","summary":"April 2 (Reuters) - Quoin Pharmaceuticals Ltd <2EBy.BE>::*QUOIN PHARMACEUTICALS ANNOUNCES ADDITIONAL POSITIVE ‘WHOLE BODY’ CLINICAL DATA FROM ONGOING PEDIATRIC NETHERTON SYNDROME STUDY AND APPROVAL TO","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250402:nRSD49shh3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","QNRX","74907L409"],"gpt_icon":0},{"id":"2522024641","title":"Quoin Pharmaceuticals Files U.S. Patent Application for Novel Topical Formulations to Treat Netherton Syndrome and Other Skin Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2522024641","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522024641?lang=en_us&edition=fundamental","pubTime":"2025-03-25 19:51","pubTimestamp":1742903505,"startTime":"0","endTime":"0","summary":"March 25 (Reuters) - Quoin Pharmaceuticals Ltd <2EBy.BE>::*QUOIN PHARMACEUTICALS FILES U.S. PATENT APPLICATION FOR NOVEL TOPICAL FORMULATIONS TO TREAT NETHERTON SYNDROME AND OTHER SKIN DISEASES*QUOIN ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nRSD3Jxzq2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNRX","74907L409","BK4139"],"gpt_icon":0},{"id":"2520347501","title":"QNRX: With Clinical Activities Expanding, QNRX Expects Cash Runway Into 2Q26","url":"https://stock-news.laohu8.com/highlight/detail?id=2520347501","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520347501?lang=en_us&edition=fundamental","pubTime":"2025-03-17 22:10","pubTimestamp":1742220600,"startTime":"0","endTime":"0","summary":"Progressing studies of QRX003; positive interim clinical data. Quoin Pharmaceuticals , a clinical stage, specialty pharmaceutical company that focuses on developing treatments for rare and orphan diseases, is expanding clinical activities studying lead asset QRX003 for the treatment of Netherton Syndrome . Quoin has active NS studies that are being conducted concurrently under an open Investigational New Drug  application with the FDA. The company believes it is the only development company developing treatment for NS that is conducting dual studies concurrently under an open IND application.The concurrent open-label study clinical studies has yielded positive interim results. Quoin believes the data generated to-date from its ongoing open-label and other studies has shown evidence that QRX003 can contribute to improvement across all measured clinical endpoints. The company expects its clinical activities will produce a solid database that will be key to its regulatory approval submiss","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/qnrx-clinical-activities-expanding-qnrx-141000728.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["QNRX","BK4139"],"gpt_icon":0},{"id":"2519983408","title":"Quoin Pharmaceuticals Ltd reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2519983408","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519983408?lang=en_us&edition=fundamental","pubTime":"2025-03-13 21:31","pubTimestamp":1741872681,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals Ltd reports results for the quarter ended December 31 - Earnings SummaryQuoin Pharmaceuticals Ltd QNRX.OQ reported a quarterly adjusted loss of 35 cents per share for the quarter","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250313:nL8N3PW17J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNRX"],"gpt_icon":0},{"id":"2519783841","title":"Quoin Pharmaceuticals FY 2024 GAAP EPS $(1.91) Beats $(2.10) Estimate, Quoin Had Approximately $14.1M In Cash, Cash Equivalents And Marketable That Is Expected To Fund The Company's Operations Into Q2 Of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2519783841","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519783841?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:37","pubTimestamp":1741865820,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals (NASDAQ:QNRX) reported quarterly losses of $(1.91) per share which beat the analyst consensus estimate of $(2.10) by 9.05 percent.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44299174/quoin-pharmaceuticals-fy-2024-gaap-eps-1-91-beats-2-10-estimate-quoin-had-approximately-14-1m-in-ca","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Quoin Pharmaceuticals FY 2024 GAAP EPS $(1.91) Beats $(2.10) Estimate, Quoin Had Approximately $14.1M In Cash, Cash Equivalents And Marketable That Is Expected To Fund The Company's Operations Into Q2 Of 2026","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNRX"],"gpt_icon":0},{"id":"2519336448","title":"Quoin Pharmaceuticals reports Q4 EPS (35c) vs ($2.08) last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2519336448","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519336448?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:36","pubTimestamp":1741865811,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals (QNRX) announced recent corporate accomplishments and provided an update on its fourth quarter and full-year 2024 progress. Q...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/quoin-pharmaceuticals-reports-q4-eps-35c-vs-2-08-last-year?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/quoin-pharmaceuticals-reports-q4-eps-35c-vs-2-08-last-year?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QNRX"],"gpt_icon":0},{"id":"2519838454","title":"Quoin Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2519838454","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519838454?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:30","pubTimestamp":1741865400,"startTime":"0","endTime":"0","summary":"ASHBURN, Va., March  13, 2025  (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the \"Company\" or \"Quoin\"), a late clinical-stage specialty pharmaceutical company focused on rare and orph","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/13/3042092/0/en/Quoin-Pharmaceuticals-Provides-Corporate-Update-and-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","QNRX"],"gpt_icon":0},{"id":"2517863714","title":"Quoin Pharmaceuticals Ltd  expected to post a loss of 46 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2517863714","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517863714?lang=en_us&edition=fundamental","pubTime":"2025-03-07 19:29","pubTimestamp":1741346945,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals Ltd  expected to post a loss of46cents a share - Earnings Preview Quoin Pharmaceuticals Ltd QNRX.OQ, QNRX.O is expected to show no change in quarterly revenue when it reports  re","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250307:nL5N3PQ0RI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNRX"],"gpt_icon":0},{"id":"2517547471","title":"Quoin Pharmaceuticals to Announce Fourth Quarter and Full-Year 2024 Financial Results on Thursday, March 13, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2517547471","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517547471?lang=en_us&edition=fundamental","pubTime":"2025-03-06 21:00","pubTimestamp":1741266000,"startTime":"0","endTime":"0","summary":"ASHBURN, Va., March  06, 2025  (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the \"Company\" or \"Quoin\"), a late clinical-stage specialty pharmaceutical company focused on rare and orph","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/06/3038132/0/en/Quoin-Pharmaceuticals-to-Announce-Fourth-Quarter-and-Full-Year-2024-Financial-Results-on-Thursday-March-13-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","QNRX"],"gpt_icon":0},{"id":"2517192615","title":"QNRX: More Positive Data Supporting Efficacy of QRX003 for NS; Campaign to Raise Awareness of the Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2517192615","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517192615?lang=en_us&edition=fundamental","pubTime":"2025-03-05 23:16","pubTimestamp":1741187760,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals  is a clinical stage, specialty pharmaceutical company that focuses on developing treatments for rare and orphan diseases, initially in the dermatology space. The company is advancing clinical studies to evaluate lead asset QRX003 for the treatment of Netherton Syndrome . Quoin has active NS studies that are being conducted concurrently under an open Investigational New Drug  application with the FDA. The company believes it is the only development company developing treatment for NS that is conducting dual studies concurrently under an open IND application. Two U.S. trials utilize the same investigators and clinical sites, which Quoin expects will result in substantial operational synergies and cost savings. QNRX is also assessing QRX003 in an NS pediatric patient in an Investigator Pediatric NS study, with plans to enroll additional pediatric patients at other sites.QNRX is advancing clinical studies to evaluate lead asset QRX003 for treatment of Netherton Syndr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/qnrx-more-positive-data-supporting-151600821.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","QNRX"],"gpt_icon":0},{"id":"2517990373","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2517990373","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517990373?lang=en_us&edition=fundamental","pubTime":"2025-03-05 19:00","pubTimestamp":1741172400,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Abercrombie & Fitch                              4Q      3.54   7:30 AM. ·ACRES Cmmcl Rlty                                 4Q       .36   4:15 PM. ·Descartes Sys Gp                                4Q       .43   5:00 PM. ·Dine Brands Global                               4Q      1.34   7:00 AM. ·Foot Locker Inc.                                  4Q       .72   6:45 AM. ·Forge Global Hldgs                              4Q      (.09)  4:10 PM. ·Global Ship Lease                                4Q      2.31   8:00 AM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMTX","FL","RSKD","MRVL","SNBR","FRGE","FSM","MRX","FDUS","TCRX","BALY","HIPO","DESP","CRMT","EYPT","CAPR","SVCO","ECOR","CRVS","SGHT","VEEV","DIN","AKA","ALNT","PAM","ARCT","ZS","IMRX","ZYME","QNRX","LB","TREE","AVGO","HDSN","GAP","BF.B","ATXS","ARQ","CNQ","GRND","ALTG","ALGS","LPSN","SKLZ","BF.A","ATER","OCGN","KR","DOMO"],"gpt_icon":1},{"id":"2516673956","title":"Quoin Pharmaceuticals Files U.S. and International Patent Applications for Novel Topical Rapamycin Formulations to Treat Rare Disease Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=2516673956","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516673956?lang=en_us&edition=fundamental","pubTime":"2025-03-04 20:30","pubTimestamp":1741091400,"startTime":"0","endTime":"0","summary":"Target Indications Include Microcystic Lymphatic Malformations, Venous Malformations and AngiofibromasProprietary Invisicare Delivery Technology Designed to Optimize Local Skin Penetration Company Pla","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/04/3036382/0/en/Quoin-Pharmaceuticals-Files-U-S-and-International-Patent-Applications-for-Novel-Topical-Rapamycin-Formulations-to-Treat-Rare-Disease-Indications.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNRX","BK4139","CVM"],"gpt_icon":0},{"id":"2514809950","title":"Quoin Pharmaceuticals Announces Highly Positive ‘Whole Body’ Clinical Data from Ongoing Pediatric Netherton Syndrome Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2514809950","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514809950?lang=en_us&edition=fundamental","pubTime":"2025-02-27 20:30","pubTimestamp":1740659400,"startTime":"0","endTime":"0","summary":"Groundbreaking data from first whole body application of QRX003 underscores potential efficacyTransformational improvement in disease state after just 2 weeks of treatment Clear visual evidence of ski","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/27/3033744/0/en/Quoin-Pharmaceuticals-Announces-Highly-Positive-Whole-Body-Clinical-Data-from-Ongoing-Pediatric-Netherton-Syndrome-Study.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNRX","BK4139","IGA"],"gpt_icon":0},{"id":"2514509508","title":"Quoin Pharmaceuticals Launches First Episode of “NETHERTON NOW” Video Series to Raise Awareness for Netherton Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2514509508","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514509508?lang=en_us&edition=fundamental","pubTime":"2025-02-25 20:30","pubTimestamp":1740486600,"startTime":"0","endTime":"0","summary":"Global Premiere Set for Rare Disease Day, Feb. 28, 2025ASHBURN, Va., Feb.  25, 2025  (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a late clinical stage spe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/25/3031904/0/en/Quoin-Pharmaceuticals-Launches-First-Episode-of-NETHERTON-NOW-Video-Series-to-Raise-Awareness-for-Netherton-Syndrome.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","IE00B19Z9Z06.USD","LU1267930730.SGD","LU2063271972.USD","LU2023250843.SGD","LU1153585028.USD","LU2125909759.SGD","BK4097","LU2125909247.SGD","LU0109392836.USD","LU0708995401.HKD","LU2458330169.SGD","LU2286300806.USD","IE00B894F039.SGD","LU0316494557.USD","QNRX","IE00B19Z9P08.USD","LU1923622614.USD","BK4550","LU0011850046.USD","LU0689472784.USD","BK4534","LU0672654240.SGD","LU0109391861.USD","LU0265550946.USD","LU1989764664.SGD","LU0320765059.SGD","LU1989772923.USD","LU2087625088.SGD","LU0265550359.USD","IE00BMPRXR70.SGD","BK4588","LU1116320901.HKD","IE00BZ9MQY76.HKD","LU0820561818.USD","LU0820561909.HKD","NOW","LU1989764748.USD","BK4608","LU0353189680.USD","LU0943347566.SGD","LU1923623000.USD","BK4607","ETH","LU1323610961.USD","LU1803068979.SGD","LU1974910355.USD","BK4585","LU1923622291.USD","BK4503"],"gpt_icon":0},{"id":"2508455607","title":"Quoin Pharmaceuticals launches ‘NETHERTON NOW’ campaign","url":"https://stock-news.laohu8.com/highlight/detail?id=2508455607","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508455607?lang=en_us&edition=fundamental","pubTime":"2025-02-04 20:37","pubTimestamp":1738672648,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals (QNRX) has launched the “NETHERTON NOW” campaign to shed light on the profound and poorly understood impacts of Netherton Syn...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/quoin-pharmaceuticals-launches-netherton-now-campaign?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/quoin-pharmaceuticals-launches-netherton-now-campaign?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0011850046.USD","LU1917777945.USD","LU0265550946.USD","LU0889565833.HKD","LU2106854487.HKD","LU0672654240.SGD","LU0320765059.SGD","BK4503","IE00B894F039.SGD","LU0354030511.USD","BK4528","LU1989772923.USD","IE00BMPRXR70.SGD","LU2023250843.SGD","LU0689472784.USD","LU2125909593.SGD","LU1267930730.SGD","IE00B19Z9Z06.USD","LU0082616367.USD","BK4581","LU1989764748.USD","LU2286300806.USD","LU1116320737.USD","BK4585","LU1116320901.HKD","LU1551013425.SGD","ETH","LU1974910355.USD","IE00BMPRXN33.USD","BK4588","BK4566","LU0354030438.USD","LU2125909916.SGD","LU1989772840.SGD","LU1989764664.SGD","LU0820561909.HKD","LU2433249047.HKD","BK4601","LU2063271972.USD","IE00BZ9MQY76.HKD","LU1923623000.USD","LU0820561818.USD","LU1064131342.USD","LU1923622291.USD","LU0348723411.USD","QNRX","LU2458330169.SGD","LU1153585028.USD","BK4543"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":48,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/QNRX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-04-09","symbol":"QNRX","defaultRemindTime":1744205400000,"type":"split","dateTimestamp":1744171200000,"forFactor":35,"toFactor":1,"ratio":35},{"market":"US","date":"2025-03-13","symbol":"QNRX","fiscalQuarterEnding":"2024/12","expectedEps":-0.44,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741838400000,"reportTimeType":"pre","actualEps":-0.35},{"market":"US","date":"2024-11-07","symbol":"QNRX","fiscalQuarterEnding":"2024/09","expectedEps":-0.44,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-0.47},{"market":"US","date":"2024-08-08","symbol":"QNRX","fiscalQuarterEnding":"2024/06","expectedEps":-0.75,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"pre","actualEps":-0.39},{"market":"US","date":"2024-05-09","symbol":"QNRX","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"pre","actualEps":-1.11}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"QNRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"QNRX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1718251200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/QNRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"QNRX","date":"2025-04-17","current":-0.393753,"percent":0.618765,"low":-17.346367,"twenty":-0.739272,"median":-0.460599,"eighty":-0.309568,"high":-0.000007,"avg":-0.814445,"sd":1.722281,"marketCap":3528996},"quantilePoints":[{"date":"2021-10-29","current":-17.346367,"twenty":-17.346367,"median":-17.346367,"eighty":-17.346367,"marketCap":97148313},{"date":"2021-11-05","current":-12.667021,"twenty":-16.958905,"median":-15.73691,"eighty":-14.60433,"marketCap":70941637},{"date":"2021-11-12","current":-8.658281,"twenty":-16.765174,"median":-12.667021,"eighty":-10.28264,"marketCap":48490695},{"date":"2021-11-19","current":-7.615115,"twenty":-14.708646,"median":-10.506176,"eighty":-8.241015,"marketCap":42648443},{"date":"2021-11-26","current":-3.943296,"twenty":-14.625193,"median":-8.598672,"eighty":-7.442247,"marketCap":37807719},{"date":"2021-12-03","current":-2.811666,"twenty":-13.054483,"median":-8.241015,"eighty":-3.931109,"marketCap":26957822},{"date":"2021-12-10","current":-3.055402,"twenty":-11.760956,"median":-7.592761,"eighty":-3.245167,"marketCap":29294723},{"date":"2021-12-17","current":-1.862838,"twenty":-10.890658,"median":-4.02164,"eighty":-3.025805,"marketCap":17860600},{"date":"2021-12-23","current":-1.549649,"twenty":-10.461469,"median":-3.943296,"eighty":-2.794256,"marketCap":16525228},{"date":"2021-12-31","current":-1.424425,"twenty":-9.308025,"median":-3.294786,"eighty":-1.787652,"marketCap":15189856},{"date":"2022-01-07","current":-1.627915,"twenty":-8.58675,"median":-3.203384,"eighty":-1.577825,"marketCap":17359836},{"date":"2022-01-14","current":-1.267895,"twenty":-8.485414,"median":-3.107631,"eighty":-1.488603,"marketCap":13520641},{"date":"2022-01-21","current":-1.0331,"twenty":-8.366195,"median":-2.876952,"eighty":-1.447905,"marketCap":11016819},{"date":"2022-01-28","current":-0.970488,"twenty":-8.163523,"median":-2.768142,"eighty":-1.377466,"marketCap":10349133},{"date":"2022-02-04","current":-1.111365,"twenty":-7.874416,"median":-1.976001,"eighty":-1.235023,"marketCap":11851426},{"date":"2022-02-11","current":-1.085306,"twenty":-7.597232,"median":-1.674874,"eighty":-1.127775,"marketCap":11573542},{"date":"2022-02-18","current":-1.061713,"twenty":-7.314087,"median":-1.573129,"eighty":-1.113525,"marketCap":11321943},{"date":"2022-02-25","current":-0.865099,"twenty":-6.348012,"median":-1.498777,"eighty":-1.105103,"marketCap":9225287},{"date":"2022-03-04","current":-0.904422,"twenty":-4.019899,"median":-1.479211,"eighty":-1.071673,"marketCap":9644618},{"date":"2022-03-11","current":-1.163952,"twenty":-3.999007,"median":-1.447905,"eighty":-1.061713,"marketCap":12412205},{"date":"2022-03-18","current":-1.163952,"twenty":-3.931109,"median":-1.416599,"eighty":-1.037796,"marketCap":12412205},{"date":"2022-03-25","current":-1.148223,"twenty":-3.765718,"median":-1.381379,"eighty":-1.057606,"marketCap":12244472},{"date":"2022-04-01","current":-1.053848,"twenty":-3.297397,"median":-1.299201,"eighty":-1.053848,"marketCap":11238077},{"date":"2022-04-08","current":-0.928015,"twenty":-3.283469,"median":-1.222936,"eighty":-1.035677,"marketCap":9896217},{"date":"2022-04-14","current":-0.476722,"twenty":-3.255613,"median":-1.205283,"eighty":-1.00962,"marketCap":10231682},{"date":"2022-04-22","current":-0.410293,"twenty":-3.203384,"median":-1.163952,"eighty":-0.975203,"marketCap":8805956},{"date":"2022-04-29","current":-0.313073,"twenty":-3.185975,"median":-1.153274,"eighty":-0.954835,"marketCap":6719363},{"date":"2022-05-06","current":-0.308697,"twenty":-3.15986,"median":-1.132494,"eighty":-0.920151,"marketCap":6625433},{"date":"2022-05-13","current":-0.243519,"twenty":-3.055402,"median":-1.120697,"eighty":-0.880828,"marketCap":5226544},{"date":"2022-05-20","current":-0.246137,"twenty":-2.907419,"median":-1.111365,"eighty":-0.857235,"marketCap":5282735},{"date":"2022-05-27","current":-0.275987,"twenty":-2.846486,"median":-1.107451,"eighty":-0.468907,"marketCap":5310410},{"date":"2022-06-03","current":-0.26812,"twenty":-2.81863,"median":-1.087972,"eighty":-0.44468,"marketCap":5159040},{"date":"2022-06-10","current":-0.203983,"twenty":-2.776847,"median":-1.085306,"eighty":-0.385285,"marketCap":3924940},{"date":"2022-06-17","current":-0.152291,"twenty":-2.489587,"median":-1.07351,"eighty":-0.319364,"marketCap":2930308},{"date":"2022-06-24","current":-0.155212,"twenty":-2.221478,"median":-1.061713,"eighty":-0.298542,"marketCap":2986515},{"date":"2022-07-01","current":-0.267305,"twenty":-1.953368,"median":-1.056579,"eighty":-0.277405,"marketCap":5143349},{"date":"2022-07-08","current":-0.231074,"twenty":-1.787652,"median":-1.053848,"eighty":-0.273302,"marketCap":4446216},{"date":"2022-07-15","current":-0.178755,"twenty":-1.674874,"median":-1.039542,"eighty":-0.267462,"marketCap":3439525},{"date":"2022-07-22","current":-0.183115,"twenty":-1.65609,"median":-1.030254,"eighty":-0.25072,"marketCap":3523416},{"date":"2022-07-29","current":-0.155517,"twenty":-1.615393,"median":-0.994864,"eighty":-0.244988,"marketCap":2992387},{"date":"2022-08-05","current":-1.0024,"twenty":-1.577825,"median":-0.983067,"eighty":-0.2438,"marketCap":19287705},{"date":"2022-08-12","current":-0.905761,"twenty":-1.530865,"median":-0.979135,"eighty":-0.244988,"marketCap":17428209},{"date":"2022-08-19","current":-1.261787,"twenty":-1.49956,"median":-0.983067,"eighty":-0.24634,"marketCap":22172308},{"date":"2022-08-26","current":-1.00506,"twenty":-1.494864,"median":-1.00373,"eighty":-0.247189,"marketCap":17661059},{"date":"2022-09-02","current":-0.83846,"twenty":-1.488603,"median":-0.983067,"eighty":-0.248209,"marketCap":14733547},{"date":"2022-09-09","current":-1.015985,"twenty":-1.47295,"median":-0.985942,"eighty":-0.249617,"marketCap":17853027},{"date":"2022-09-16","current":-0.999598,"twenty":-1.447905,"median":-1.000999,"eighty":-0.2541,"marketCap":17565075},{"date":"2022-09-23","current":-0.80537,"twenty":-1.447905,"median":-0.994135,"eighty":-0.255867,"marketCap":14152083},{"date":"2022-09-30","current":-0.61506,"twenty":-1.446166,"median":-0.983139,"eighty":-0.262906,"marketCap":10807926},{"date":"2022-10-07","current":-0.604028,"twenty":-1.436253,"median":-0.98189,"eighty":-0.267383,"marketCap":10614062},{"date":"2022-10-14","current":-0.471638,"twenty":-1.42286,"median":-0.968913,"eighty":-0.267782,"marketCap":8287692},{"date":"2022-10-21","current":-0.562656,"twenty":-1.413468,"median":-0.966397,"eighty":-0.2688,"marketCap":9887072},{"date":"2022-10-28","current":-0.529559,"twenty":-1.393119,"median":-0.950476,"eighty":-0.271699,"marketCap":9305479},{"date":"2022-11-04","current":-0.485429,"twenty":-1.358698,"median":-0.943659,"eighty":-0.272858,"marketCap":8530023},{"date":"2022-11-11","current":-0.479672,"twenty":-1.345188,"median":-0.923004,"eighty":-0.274906,"marketCap":9208547},{"date":"2022-11-18","current":-0.459476,"twenty":-1.332632,"median":-0.91334,"eighty":-0.276144,"marketCap":8820819},{"date":"2022-11-25","current":-0.462,"twenty":-1.299201,"median":-0.906739,"eighty":-0.276772,"marketCap":8869285},{"date":"2022-12-02","current":-0.441804,"twenty":-1.267895,"median":-0.903164,"eighty":-0.277827,"marketCap":8481557},{"date":"2022-12-09","current":-0.393836,"twenty":-1.261787,"median":-0.893083,"eighty":-0.277839,"marketCap":7560702},{"date":"2022-12-16","current":-0.386263,"twenty":-1.226868,"median":-0.869031,"eighty":-0.278907,"marketCap":7415304},{"date":"2022-12-23","current":-0.333246,"twenty":-1.219003,"median":-0.857235,"eighty":-0.28331,"marketCap":6397517},{"date":"2022-12-30","current":-0.358492,"twenty":-1.214288,"median":-0.83846,"eighty":-0.285895,"marketCap":6882177},{"date":"2023-01-06","current":-0.366066,"twenty":-1.203717,"median":-0.830267,"eighty":-0.294872,"marketCap":7027575},{"date":"2023-01-13","current":-0.419082,"twenty":-1.196726,"median":-0.751587,"eighty":-0.305389,"marketCap":8045362},{"date":"2023-01-20","current":-0.388787,"twenty":-1.192762,"median":-0.704699,"eighty":-0.310447,"marketCap":7463770},{"date":"2023-01-27","current":-0.393836,"twenty":-1.178108,"median":-0.684013,"eighty":-0.314277,"marketCap":7560702},{"date":"2023-02-03","current":-0.59078,"twenty":-1.163952,"median":-0.661949,"eighty":-0.317723,"marketCap":11341538},{"date":"2023-02-10","current":-0.421607,"twenty":-1.163758,"median":-0.631609,"eighty":-0.320717,"marketCap":8093828},{"date":"2023-02-17","current":-0.353443,"twenty":-1.161409,"median":-0.60749,"eighty":-0.323804,"marketCap":6785245},{"date":"2023-02-24","current":-0.118656,"twenty":-1.156304,"median":-0.591888,"eighty":-0.313675,"marketCap":2277903},{"date":"2023-03-03","current":-0.281484,"twenty":-1.14665,"median":-0.562656,"eighty":-0.29262,"marketCap":5403806},{"date":"2023-03-10","current":-0.522124,"twenty":-1.138785,"median":-0.550992,"eighty":-0.287367,"marketCap":4898302},{"date":"2023-03-17","current":-0.593625,"twenty":-1.130921,"median":-0.551624,"eighty":-0.29122,"marketCap":5569088},{"date":"2023-03-24","current":-0.65651,"twenty":-1.124629,"median":-0.575443,"eighty":-0.294825,"marketCap":6159049},{"date":"2023-03-31","current":-0.60057,"twenty":-1.123056,"median":-0.592995,"eighty":-0.300426,"marketCap":5634244},{"date":"2023-04-06","current":-0.603601,"twenty":-1.116764,"median":-0.60057,"eighty":-0.300426,"marketCap":5662676},{"date":"2023-04-14","current":-0.560679,"twenty":-1.116764,"median":-0.592742,"eighty":-0.308697,"marketCap":5260010},{"date":"2023-04-21","current":-0.580997,"twenty":-1.111365,"median":-0.593625,"eighty":-0.313073,"marketCap":5450622},{"date":"2023-04-28","current":-0.649313,"twenty":-1.111365,"median":-0.598171,"eighty":-0.316082,"marketCap":6091523},{"date":"2023-05-05","current":-0.60259,"twenty":-1.111365,"median":-0.60259,"eighty":-0.320185,"marketCap":5653199},{"date":"2023-05-12","current":-0.55198,"twenty":-1.103538,"median":-0.60158,"eighty":-0.321514,"marketCap":5686369},{"date":"2023-05-19","current":-0.55198,"twenty":-1.10065,"median":-0.595771,"eighty":-0.327238,"marketCap":5686369},{"date":"2023-05-26","current":-0.505982,"twenty":-1.088059,"median":-0.592742,"eighty":-0.333246,"marketCap":5212505},{"date":"2023-06-02","current":-0.499658,"twenty":-1.08792,"median":-0.589505,"eighty":-0.344867,"marketCap":5147361},{"date":"2023-06-09","current":-0.55704,"twenty":-1.087172,"median":-0.580997,"eighty":-0.350289,"marketCap":5738494},{"date":"2023-06-16","current":-0.620978,"twenty":-1.085644,"median":-0.584704,"eighty":-0.352938,"marketCap":6397166},{"date":"2023-06-23","current":-0.676176,"twenty":-1.085306,"median":-0.589505,"eighty":-0.356472,"marketCap":6965803},{"date":"2023-06-30","current":-0.593264,"twenty":-1.083207,"median":-0.591634,"eighty":-0.359502,"marketCap":6111663},{"date":"2023-07-07","current":-0.517481,"twenty":-1.079536,"median":-0.587708,"eighty":-0.361522,"marketCap":5330971},{"date":"2023-07-14","current":-0.54646,"twenty":-1.077168,"median":-0.582224,"eighty":-0.364046,"marketCap":5629506},{"date":"2023-07-21","current":-0.623853,"twenty":-1.07607,"median":-0.587708,"eighty":-0.366571,"marketCap":6426782},{"date":"2023-07-28","current":-0.721599,"twenty":-1.07607,"median":-0.591634,"eighty":-0.36859,"marketCap":7433744},{"date":"2023-08-04","current":-0.757094,"twenty":-1.073339,"median":-0.593264,"eighty":-0.36859,"marketCap":7374510},{"date":"2023-08-11","current":-0.62027,"twenty":-1.070607,"median":-0.595859,"eighty":-0.371115,"marketCap":6041768},{"date":"2023-08-18","current":-0.543243,"twenty":-1.069577,"median":-0.593625,"eighty":-0.376164,"marketCap":5291483},{"date":"2023-08-25","current":-0.538176,"twenty":-1.067876,"median":-0.592742,"eighty":-0.378689,"marketCap":5242122},{"date":"2023-09-01","current":-0.58277,"twenty":-1.065691,"median":-0.589505,"eighty":-0.378689,"marketCap":5676497},{"date":"2023-09-08","current":-0.590878,"twenty":-1.063086,"median":-0.590829,"eighty":-0.378689,"marketCap":5755475},{"date":"2023-09-15","current":-0.569594,"twenty":-1.061713,"median":-0.58823,"eighty":-0.378689,"marketCap":5548159},{"date":"2023-09-22","current":-0.506757,"twenty":-1.061713,"median":-0.585904,"eighty":-0.378689,"marketCap":4936085},{"date":"2023-09-29","current":-0.433865,"twenty":-1.060727,"median":-0.581611,"eighty":-0.380709,"marketCap":4226078},{"date":"2023-10-06","current":-0.427703,"twenty":-1.05818,"median":-0.578696,"eighty":-0.383738,"marketCap":4166055},{"date":"2023-10-13","current":-0.408953,"twenty":-1.055487,"median":-0.574156,"eighty":-0.383738,"marketCap":3983420},{"date":"2023-10-20","current":-0.41554,"twenty":-1.053848,"median":-0.568243,"eighty":-0.383738,"marketCap":4047589},{"date":"2023-10-27","current":-0.435811,"twenty":-1.053848,"median":-0.56578,"eighty":-0.383738,"marketCap":4245033},{"date":"2023-11-03","current":-0.435811,"twenty":-1.053848,"median":-0.56554,"eighty":-0.384243,"marketCap":4245033},{"date":"2023-11-10","current":-0.411508,"twenty":-1.050251,"median":-0.562656,"eighty":-0.384243,"marketCap":4008308},{"date":"2023-11-17","current":-0.498316,"twenty":-1.046658,"median":-0.560987,"eighty":-0.385884,"marketCap":4304279},{"date":"2023-11-24","current":-0.522671,"twenty":-1.041435,"median":-0.560318,"eighty":-0.386263,"marketCap":4514655},{"date":"2023-12-01","current":-0.568388,"twenty":-1.035221,"median":-0.558953,"eighty":-0.387777,"marketCap":4909543},{"date":"2023-12-08","current":-0.568034,"twenty":-1.0331,"median":-0.560318,"eighty":-0.388787,"marketCap":4906483},{"date":"2023-12-15","current":-0.484601,"twenty":-1.031392,"median":-0.558953,"eighty":-0.389637,"marketCap":4185812},{"date":"2023-12-22","current":-0.477732,"twenty":-1.021693,"median":-0.557743,"eighty":-0.390868,"marketCap":4126480},{"date":"2023-12-29","current":-0.588241,"twenty":-1.014712,"median":-0.55704,"eighty":-0.391312,"marketCap":5081023},{"date":"2024-01-05","current":-0.532603,"twenty":-1.010893,"median":-0.55589,"eighty":-0.391312,"marketCap":4600445},{"date":"2024-01-12","current":-0.526889,"twenty":-1.007253,"median":-0.553378,"eighty":-0.393331,"marketCap":4551084},{"date":"2024-01-19","current":-0.454873,"twenty":-1.0057,"median":-0.55198,"eighty":-0.393836,"marketCap":3929036},{"date":"2024-01-26","current":-0.427454,"twenty":-1.003464,"median":-0.551802,"eighty":-0.393836,"marketCap":3692202},{"date":"2024-02-02","current":-0.394309,"twenty":-1.000719,"median":-0.549335,"eighty":-0.39412,"marketCap":3405909},{"date":"2024-02-09","current":-0.38288,"twenty":-0.99632,"median":-0.548588,"eighty":-0.392826,"marketCap":3307187},{"date":"2024-02-16","current":-0.318876,"twenty":-0.989219,"median":-0.547495,"eighty":-0.388787,"marketCap":2754343},{"date":"2024-02-23","current":-0.301732,"twenty":-0.98485,"median":-0.546977,"eighty":-0.385127,"marketCap":2606260},{"date":"2024-03-01","current":-0.314316,"twenty":-0.983153,"median":-0.545642,"eighty":-0.383738,"marketCap":2714953},{"date":"2024-03-08","current":-0.135997,"twenty":-0.983067,"median":-0.543349,"eighty":-0.379908,"marketCap":1174693},{"date":"2024-03-15","current":-0.20704,"twenty":-0.982596,"median":-0.542611,"eighty":-0.378689,"marketCap":1798470},{"date":"2024-03-22","current":-0.381897,"twenty":-0.979215,"median":-0.541631,"eighty":-0.378689,"marketCap":3317373},{"date":"2024-03-28","current":-0.369167,"twenty":-0.97426,"median":-0.540481,"eighty":-0.37767,"marketCap":3206793},{"date":"2024-04-05","current":-0.364923,"twenty":-0.969858,"median":-0.539696,"eighty":-0.377263,"marketCap":3169934},{"date":"2024-04-12","current":-0.326734,"twenty":-0.967338,"median":-0.538176,"eighty":-0.369557,"marketCap":2838196},{"date":"2024-04-19","current":-0.305517,"twenty":-0.96715,"median":-0.536661,"eighty":-0.365152,"marketCap":2653898},{"date":"2024-04-26","current":-0.267328,"twenty":-0.964085,"median":-0.533552,"eighty":-0.358997,"marketCap":2322161},{"date":"2024-05-03","current":-0.309761,"twenty":-0.95419,"median":-0.531461,"eighty":-0.351423,"marketCap":2690758},{"date":"2024-05-10","current":-0.337342,"twenty":-0.951156,"median":-0.528981,"eighty":-0.340821,"marketCap":2930346},{"date":"2024-05-17","current":-0.367202,"twenty":-0.948223,"median":-0.527946,"eighty":-0.340821,"marketCap":3088456},{"date":"2024-05-24","current":-0.34075,"twenty":-0.943728,"median":-0.525421,"eighty":-0.340947,"marketCap":2865976},{"date":"2024-05-31","current":-0.331712,"twenty":-0.943659,"median":-0.525,"eighty":-0.340592,"marketCap":2789958},{"date":"2024-06-07","current":-0.346334,"twenty":-0.928015,"median":-0.523469,"eighty":-0.340703,"marketCap":2912940},{"date":"2024-06-14","current":-0.340703,"twenty":-0.926289,"median":-0.522398,"eighty":-0.340681,"marketCap":2865578},{"date":"2024-06-21","current":-0.295228,"twenty":-0.922433,"median":-0.519905,"eighty":-0.336816,"marketCap":2483103},{"date":"2024-06-28","current":-0.279187,"twenty":-0.920151,"median":-0.518004,"eighty":-0.336018,"marketCap":2348182},{"date":"2024-07-05","current":-0.274313,"twenty":-0.920151,"median":-0.512285,"eighty":-0.333064,"marketCap":2307188},{"date":"2024-07-12","current":-0.307579,"twenty":-0.914702,"median":-0.509745,"eighty":-0.331195,"marketCap":2586980},{"date":"2024-07-15","current":-0.310418,"twenty":-0.91334,"median":-0.508665,"eighty":-0.331019,"marketCap":2610860},{"date":"2024-08-02","current":-0.272562,"twenty":-0.913129,"median":-0.507585,"eighty":-0.329729,"marketCap":2292462},{"date":"2024-08-09","current":-0.248051,"twenty":-0.911177,"median":-0.505359,"eighty":-0.325114,"marketCap":2086300},{"date":"2024-08-16","current":-0.24035,"twenty":-0.906543,"median":-0.501744,"eighty":-0.319687,"marketCap":1989587},{"date":"2024-08-23","current":-0.293286,"twenty":-0.905493,"median":-0.497744,"eighty":-0.316091,"marketCap":2427781},{"date":"2024-08-30","current":-0.286555,"twenty":-0.903919,"median":-0.49203,"eighty":-0.313322,"marketCap":2372062},{"date":"2024-09-06","current":-0.383339,"twenty":-0.901905,"median":-0.490945,"eighty":-0.313073,"marketCap":3173230},{"date":"2024-09-13","current":-0.311556,"twenty":-0.894391,"median":-0.486542,"eighty":-0.313073,"marketCap":2579020},{"date":"2024-09-20","current":-0.276506,"twenty":-0.893083,"median":-0.485429,"eighty":-0.309761,"marketCap":2288880},{"date":"2024-09-27","current":-0.252418,"twenty":-0.880828,"median":-0.484661,"eighty":-0.307436,"marketCap":2089484},{"date":"2024-10-04","current":-0.23434,"twenty":-0.872964,"median":-0.484601,"eighty":-0.302929,"marketCap":1939837},{"date":"2024-10-11","current":-0.252827,"twenty":-0.865099,"median":-0.482434,"eighty":-0.301027,"marketCap":2092867},{"date":"2024-10-18","current":-0.317326,"twenty":-0.857235,"median":-0.47841,"eighty":-0.300426,"marketCap":2626780},{"date":"2024-10-25","current":-0.39995,"twenty":-0.857235,"median":-0.476537,"eighty":-0.300426,"marketCap":3310734},{"date":"2024-10-31","current":-0.494182,"twenty":-0.850943,"median":-0.478071,"eighty":-0.300907,"marketCap":4090778},{"date":"2024-11-08","current":-0.422626,"twenty":-0.840642,"median":-0.476351,"eighty":-0.301191,"marketCap":3498446},{"date":"2024-11-15","current":-0.352287,"twenty":-0.834605,"median":-0.468894,"eighty":-0.301334,"marketCap":3065275},{"date":"2024-11-22","current":-0.359821,"twenty":-0.830942,"median":-0.464302,"eighty":-0.301657,"marketCap":3130826},{"date":"2024-11-29","current":-0.348213,"twenty":-0.815329,"median":-0.462,"eighty":-0.30245,"marketCap":3029832},{"date":"2024-12-06","current":-0.435267,"twenty":-0.804556,"median":-0.461782,"eighty":-0.30359,"marketCap":3787290},{"date":"2024-12-13","current":-0.420758,"twenty":-0.775862,"median":-0.460599,"eighty":-0.304922,"marketCap":3661047},{"date":"2024-12-20","current":-0.375374,"twenty":-0.755346,"median":-0.458782,"eighty":-0.305517,"marketCap":3266158},{"date":"2024-12-27","current":-0.324419,"twenty":-0.754181,"median":-0.457684,"eighty":-0.304625,"marketCap":2822793},{"date":"2025-01-03","current":-0.389709,"twenty":-0.753938,"median":-0.457139,"eighty":-0.305517,"marketCap":3390886},{"date":"2025-01-10","current":-0.36162,"twenty":-0.752966,"median":-0.455912,"eighty":-0.305517,"marketCap":3146480},{"date":"2025-01-17","current":-0.342177,"twenty":-0.750208,"median":-0.452331,"eighty":-0.307436,"marketCap":2977309},{"date":"2025-01-24","current":-0.238758,"twenty":-0.74342,"median":-0.451013,"eighty":-0.307052,"marketCap":2077454},{"date":"2025-01-31","current":-0.167665,"twenty":-0.737124,"median":-0.449377,"eighty":-0.30269,"marketCap":1458864},{"date":"2025-02-07","current":-0.757086,"twenty":-0.737124,"median":-0.448569,"eighty":-0.301334,"marketCap":6587465},{"date":"2025-02-14","current":-0.783111,"twenty":-0.74342,"median":-0.449855,"eighty":-0.301657,"marketCap":6813909},{"date":"2025-02-21","current":-0.78737,"twenty":-0.751311,"median":-0.451168,"eighty":-0.30245,"marketCap":6850964},{"date":"2025-02-28","current":-0.840366,"twenty":-0.753452,"median":-0.452677,"eighty":-0.30359,"marketCap":7312086},{"date":"2025-03-07","current":-0.710242,"twenty":-0.753452,"median":-0.457022,"eighty":-0.304922,"marketCap":6179866},{"date":"2025-03-14","current":-0.697939,"twenty":-0.751311,"median":-0.45752,"eighty":-0.305517,"marketCap":6072819},{"date":"2025-03-21","current":-0.666099,"twenty":-0.746669,"median":-0.458782,"eighty":-0.306668,"marketCap":5969890},{"date":"2025-03-28","current":-0.654614,"twenty":-0.742758,"median":-0.460599,"eighty":-0.307522,"marketCap":5866961},{"date":"2025-04-04","current":-0.597422,"twenty":-0.741572,"median":-0.462322,"eighty":-0.30825,"marketCap":5354374},{"date":"2025-04-11","current":-0.360284,"twenty":-0.741572,"median":-0.462,"eighty":-0.309143,"marketCap":3229031},{"date":"2025-04-17","current":-0.393753,"twenty":-0.739272,"median":-0.460599,"eighty":-0.309568,"marketCap":3528996}],"updateTime":1745263366217}}}